Citius Pharmaceuticals
CTXR
CTXR
74 hedge funds and large institutions have $30.4M invested in Citius Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.25% more ownership
Funds ownership: 0.39% → 0.64% (+0.25%)
Holders
74
Holding in Top 10
–
Calls
$721K
Puts
$71K
Top Buyers
| 1 | +$6.89M | |
| 2 | +$1.96M | |
| 3 | +$1.52M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$940K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$752K |
Top Sellers
| 1 | -$371K | |
| 2 | -$290K | |
| 3 | -$209K | |
| 4 |
WAS
Wealth Advisory Solutions
Indiianapolis,
Indiana
|
-$182K |
| 5 |
Man Group
London,
United Kingdom
|
-$155K |